Tags Posts tagged with "Naloxone"


Harm Reduction Therapeutics (HRT), a non-profit pharmaceutical company, has shipped the first order of RiVive, an over-the-counter naloxone nasal spray to prevent opioid overdose deaths. The FDA-approved nasal spray provides a single 3 mg administration for the emergency treatment of opioid overdose without a prescription. RiVive will be distributed to community harm reduction groups that are working to combat opioid overdoses, and HRT is committed to its non-profit model and aims to make RiVive available across the United States free of charge or at a low cost.

HRT emphasizes that no entity or individual, including its unpaid volunteer board of directors and staff, will profit from RiVive sales. The product will be available at cost or less, with a selling price of $36 per twin pack, covering production, packaging, testing, and transportation costs. Additionally, HRT actively seeks additional funding partners to support operations, reduce selling prices, and increase the availability of free-of-charge doses, highlighting the importance of charitable contributions in saving lives amid the opioid crisis.

Read the full press release.

The Wolf Administration on Thursday announced the expansion of Acting Secretary of Health and Pennsylvania Physician General Dr. Denise Johnson’s naloxone standing order to now include ZIMHI, a 5 milligram (mg) intra-muscular injection device that comes as a single-dose pre-filled syringe or a carton containing two cases of pre-filled syringes. Residents can present a copy of the standing order at their local pharmacy to obtain life-saving naloxone.

Read the full press release.

Since 2017, Pennsylvania has taken several steps to increase naloxone access for people and communities across the commonwealth who need it the most. With a recent increase in drug overdose deaths (the majority of which are opioid- and fentanyl-related), Pennsylvania is anticipating a significant supply of naloxone in the coming months. The Department of Drug and Alcohol Programs is encouraging individuals, organizations, and agencies to learn how to access this naloxone at no cost.